Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties
about
The histamine H3 receptor: an attractive target for the treatment of cognitive disordersDetection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligandGlobal analysis of small molecule binding to related protein targetsEffects of the cognition-enhancing agent ABT-239 on fetal ethanol-induced deficits in dentate gyrus synaptic plasticityEffects of a novel cognition-enhancing agent on fetal ethanol-induced learning deficits.Histamine H3 receptor ligands break ground in a remarkable plethora of therapeutic areas.Preclinical evaluation of the abuse potential of Pitolisant, a histamine H₃ receptor inverse agonist/antagonist compared with ModafinilUse of the H3 receptor antagonist radioligand [3H]-A-349821 to reveal in vivo receptor occupancy of cognition enhancing H3 receptor antagonistsThe Histamine H3 Receptor: Structure, Pharmacology, and Function.Structure-based prediction of subtype selectivity of histamine H3 receptor selective antagonists in clinical trialsRecent advances in the development of histamine H3 antagonists.Histamine h3 receptor: a novel therapeutic target in alcohol dependence?H3 receptor antagonism enhances NCAM PSA-mediated plasticity and improves memory consolidation in odor discrimination and delayed match-to-position paradigms.Assessment of the abuse liability of ABT-288, a novel histamine H₃ receptor antagonist.
P2860
Q24654788-7CFD6860-6BAF-4709-8EAC-34EA4A38B0F1Q24675612-4817F02E-1C9E-4EB6-94C9-69FA1BEE18FDQ28478884-86838315-299E-4776-A101-D7B9AC29EC04Q34028177-32D0901E-12D6-45EE-A5F7-660C42684118Q36846466-5324D11C-8088-4026-8487-F57401F90CAFQ36861579-DC175400-01D8-4DAB-9729-C57380CDB552Q36929453-B173253B-476A-4208-AE00-F697F544A597Q37230899-DCCC6D36-3D78-4E3E-A973-5E1657884F09Q38937634-6226F06F-865E-4D2E-B22A-D00C60ED6438Q40003951-87F35746-E55D-4062-A938-00F05BD80A31Q40208576-AD1C67D2-3A94-4D73-A635-981F1C5F63EBQ41883032-9D8938FA-990E-41B9-A110-76BB8FED1424Q42458022-B1A10A94-7A39-45F5-88A4-21B977DB7CD1Q48030646-5C3A154B-8795-48D7-A534-CD4053C57B1B
P2860
Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: I. Potent and selective histamine H3 receptor antagonist with drug-like properties
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Pharmacological properties of ...... nist with drug-like properties
@ast
Pharmacological properties of ...... nist with drug-like properties
@en
Pharmacological properties of ...... nist with drug-like properties
@nl
type
label
Pharmacological properties of ...... nist with drug-like properties
@ast
Pharmacological properties of ...... nist with drug-like properties
@en
Pharmacological properties of ...... nist with drug-like properties
@nl
prefLabel
Pharmacological properties of ...... nist with drug-like properties
@ast
Pharmacological properties of ...... nist with drug-like properties
@en
Pharmacological properties of ...... nist with drug-like properties
@nl
P2093
P356
P1476
Pharmacological properties of ...... nist with drug-like properties
@en
P2093
Arthur A Hancock
Betty B Yao
Chae Hee Kang
David G Witte
Gerard B Fox
James P Sullivan
Jill Wetter
Kathleen M Krueger
Kennan Marsh
Liping Pan
P304
P356
10.1124/JPET.104.078303
P407
P577
2005-04-01T00:00:00Z